Search

Author/Creator Armstrong, Deborah

4. Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial. Issue 5 (May 2021)

Authors:
Poveda, Andrés; Floquet, Anne; Ledermann, Jonathan A; Asher, Rebecca; Penson, Richard T; Oza, Amit M; Korach, Jacob; Huzarski, Tomasz; Pignata, Sandro; Friedlander, Michael; Baldoni, Alessandra; Park-Simon, Tjoung-Won; Tamura, Kenji; Sonke, Gabe S; Lisyanskaya, Alla; Kim, Jae-Hoon; Filho, Elias A...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 5(2021)
Page Start:
620
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Racial disparities in the rate of cardiotoxicity of HER2‐targeted therapies among women with early breast cancer. Issue 9 (30th January 2018)

Authors:
Litvak, Anya; Batukbhai, Bhavina; Russell, Stuart D.; Tsai, Hua‐Ling; Rosner, Gary L.; Jeter, Stacie C.; Armstrong, Deborah; Emens, Leisha A.; Fetting, John; Wolff, Antonio C.; Silhy, Raquel; Stearns, Vered; Connolly, Roisin M.
Journal:
Cancer
Issue:
Volume 124:Issue 9(2018)
Page Start:
1904
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗